Company / Cash & Equivalents
SOLESENCE, INC. Cash & Equivalents History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$1.3M
FY2025
5-year range
$657.0K / $2.2M
FY2021-FY2025
Trend
-8.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 3 consecutive years, from $2M in FY2022 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 10-year CAGR of -3.6%.
Declined from $2M to $1M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -16.2%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -3.6%
Key checks
Key Insights
- SOLESENCE, INC.'s cash & equivalents has declined for 3 consecutive years.
- 5-year CAGR of +6.1%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 8.6% year-over-year.
- Peak cash & equivalents was recorded in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3M | -8.6% |
| FY2024 | $1.4M | -18.2% |
| FY2023 | $1.7M | -21.2% |
| FY2022 | $2.2M | +232.7% |
| FY2021 | $657.0K | -31.3% |
| FY2020 | $957.0K | -19.8% |
| FY2019 | $1.2M | -32.9% |
| FY2017 | $1.8M | +39.5% |
| FY2016 | $1.3M | -31.5% |
| FY2015 | $1.9M | -43.2% |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026